Gene Therapy as a Treatment of Primary Immune Defects
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon H
1.00 CME/CE

Learning Objectives:
  1. Discuss and analyze general information about gene therapy
  2. Discuss current indications for gene therapy in patients with primary immunodeficiency
  3. Evaluate considerations of future use of gene therapy in primary immunodeficiency disorders
Discussion Leader
Andrew M. Scharenberg, MD
Discussion Leader
Donald B. Kohn, MD
See more of: Session